跳到正文
原文
FDA · 药品动态·· 2 天前精选AI 评分58

一款肾病药物获FDA批准,关键疾病标志物降低43%

His Kidney Drug Just Won FDA Approval After Cutting a Key Disease Marker by 43%. One $74,730 Infusion Could Leave Him Owing Nearly $15,000 Under Original Medicare - 24/7 Wall St.

AI 导读

一款肾病药物获FDA批准,关键疾病标志物降低43%。该药单次输注费用为74,730美元,在Original Medicare下患者可能自付近15,000美元。

推荐理由

材料仅给出获批与降价幅度、费用数字,未提供药品名与适应症,可读价值有限。

来源:FDA · 药品动态 · news.google.com